Languages
Pages
Legal
Explore all categories to find your favorite topic
Slide 1 A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With Coronary In-Stent Restenosis of Drug- Eluting Stents:…
Comparison of the ABSORBTM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction:
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease The new england…
Accepted Manuscript Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients with Diabetes Mellitus: Results of the Absorb Diabetic…
8/4/2019 Drug-Eluting Stents and Other Anti-Restenosis Devices 1/21842 Rev Esp Cardiol. 2005;58(7):842-62 104Restenosis remains as the main limitation of percuta-neous coronary…
Central Bringing Excellence in Open Access JSM Heart Surgery: Cases Images Cite this article: el Mokadem M 2018 Drug Eluting Stent Restenosis JSM Heart Surg Case…
English Deutsch Svenska Dansk Polski Česky Türkçe Norsk Italiano Suomi Français Español Pусский Português Nederlands Ελληνικά Magyar Български…
ABSORB II : A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease…
EL2099886 91615 Page 1 of 107 XIENCE Alpine™ Everolimus Eluting Coronary Stent Systems Instructions for Use Table of Contents 10 PRODUCT DESCRIPTION 11 Device Component…
EVEROLIMUS ELUTING CORONARY STENTS FOR LONG INFRA-POPLITEAL LESIONS FOR CRITICAL LIMB ISCHEMIA: LONG DES-BTK Robert Lookstein MD MHCDL FSIR FAHA FSVM Professor of Radiology…
1. HEART INSTITUTE 2. Prediction of restenosis after PCI withcontemporary drug-eluting stents DR. ASHOK SETHFRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc.CHAIRMAN…
HEART INSTITUTE Prediction of restenosis after PCI with contemporary drug-eluting stents FRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc. DR. ASHOK SETH CHAIRMAN…
Slide 1 Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents Slide 2 Balloon Angioplasty minimally invasive treatment to open blocked arteries.…
Thesis presentation Presenter Dr Praveen Gupta Moderator Dr Raja Selvaraj MD(Ped) DNB(Card) Fellowship in Cardiac EP(Toronto) Cardiac Electrophysiologist Associate Professor…
Newer Generation Drug-Eluting Stents: What is the Promise Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University…
The XIENCE V® and XIENCE nano m Everolimus Eluting Coronary Stent System Instructions for Use Table of Contents ONLY 10 PRODUCT DESCRIPTION 11 Device Component Description…
The XIENCE T M V Everolimus Eluting Coronary Stent System Instructions for Use ONLY Table of Contents 10 PRODUCT DESCRIPTION 11 Device Component Description 12 Drug Component…
Slide 1Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A. Byrne, Julinda…
The Treatment of In- Stent Restenosis Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh MY CONFLICTS OF INTEREST ARE Travel Accomodation Registration § …
Slide 1 Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary…